The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
huang zuo zhu she ye dui lao nian guan xin bing huan zhe xue xiao ban huo hua zhuang tai de ying xiang
Author(s): 
Pages: 338-339
Year: Issue:  3
Journal: Qianwei Journal of Medicine & Pharmacy

Keyword:  黄芪注射液冠心病血小板活化;
Abstract: 黄芪注射液已广泛应用于临床治疗多种疾病,但其对老年冠心病患者外周血小板活化状态的影响尚少见报道,我们对老年冠心病患者治疗前后外周血小板CD62p和CD41及CD61进行了检测,旨在探讨黄芪注射液对冠心病患者血小板活化状态的影响。1资料与方法1.1一般资料对照组男30名,平均年龄71.5岁。均系健康查体者,各项检查指标均在正常范围。冠心病组70例。男59例、女11例。平均年龄72.8岁。为已确诊冠心病收住院的患者。冠心病诊断均符合冠心病临床命名及诊断标准眼1演。将患者随机分为2组,黄芪组:38例,在常规西药基础上每日静脉滴注黄芪注射液10ml(相当黄芪20g),黄芪注射液产自上海福达制药有限公司
Related Articles
No related articles found